Exciting that we have another new target that Recce are excited about! Let's add to the list of indications that have been announced and tested over the years:
- burns
- h pylori
- sepsis
- uro sepsis
- COVID
- mycobacterium
- hamsters
- sinus infections
- influenza
But now, it's LUNG INFECTIONS we're excited about! Forget those other things, lung infections are what we're all about now.
[INTERVIEW] Recce Pharmaceuticals accelerates commercialisation with positive Phase II results, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $104.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $58.28K | 167.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5009 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 15844 | 2 |
View Market Depth
| Last trade - 11.07am 22/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |